Market Signal Briefing

mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in checkpoint inhibitor-resistant/refractory(CPI-R/R) melanoma patients will be presented at the 2025 European Society for Medical Oncology (ESMO) Congress, October 17-21, 2025, in Berlin, Germany. mRNA-4359 is an investigational immune-evasion targeted cancer antigen therapy (CAT) that encodes epitopes of two common immune escape pathways, PD-L1 and IDO1, to elicit antigen-specific T cell responses that may directly kill tumor cells and deplete tumor suppressor cells.

Six oral presentations highlight Signatera’s expanding role across solid tumors, including definitive predictive data in adjuvant bladder cancer

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 14 studies featuring its technology will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 17–21 in Berlin, Germany. The slate includes six oral presentations, reinforcing Natera’s position as a leader in molecular residual disease (MRD) testing across multiple cancer types.

Bladder Cancer Highlights

The IMvigor011 trial, sponsored by Genentech, a member of the Roche Group, has been selected for a Presidential Symposium on October 20. With positive topline results announced in August, this oral presentation will include additional data on Signatera’s ability to predict disease-free survival (DFS) and overall survival (OS) benefit from adjuvant Tecentriq® (atezolizumab) in muscle-invasive bladder cancer (MIBC). IMvigor011 is the first prospective, phase III study in MIBC to be read out that uses a bespoke MRD-guided approach.

MRD analysis from the Phase 3 CheckMate 274 trial will also be shared in an oral presentation on October 17. CheckMate 274 randomized high-risk MIBC patients 1:1 to Opdivo® (nivolumab) or placebo for ≤ 1 year of adjuvant treatment. The results showed that DFS for Signatera-positive patients treated with nivolumab more than doubled compared to placebo (7.4 months vs 2.8 months; HR: 0.35). In contrast, no significant improvement in DFS was observed with the use of nivolumab among Signatera-negative patients.

Additional ESMO Data

Additional oral presentations include results from the SunRISe-4 trial in MIBC, the INTERCEPT trial in colorectal cancer, and Natera’s early cancer detection program.

“Across multiple different Phase 3 trials, we’ve now shown how Signatera MRD can help identify patients with bladder cancer who are most likely to benefit from adjuvant immunotherapy,” said Matthew Galsky, M.D., Lillian and Howard Stratton Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Associate Director for Translational Research at the Tisch Cancer Center. “These key studies are building a powerful foundation for bespoke MRD to guide different forms of treatment, improve outcomes for patients with bladder cancer and change medical practice.”

“We are proud to showcase the breadth of research using Signatera at this year’s ESMO Congress, including oral presentations across bladder, colorectal, breast, and other cancers,” said Minetta Liu, M.D., chief medical officer of oncology at Natera. “The diversity of these datasets underscores the growing impact of bespoke MRD assessment in reshaping how we detect and monitor cancer, providing tools to personalize treatment recommendations in oncology–with the ultimate goal of improving outcomes for patients.”

Full list of presentations featuring Natera’s technology at ESMO includes:

October 17, 2:50 PM CEST | 3068O (Oral Presentation)

Presenter: Matthew D. Galsky, M.D.

Adjuvant nivolumab vs placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274

October 17, 4:40 PM CEST | LBA 112 (Mini Oral Presentation)

Presenter: Andrea Necchi, M.D.

Neoadjuvant gemcitabine intravesical system (TAR-200) + cetrelimab (CET) or CET alone in patients (pts) with muscle-invasive bladder cancer (MIBC): SunRISe-4 (SR-4) primary analysis and biomarker results

October 18, 9:00 AM CEST | 185eP

Presenter: Michael Galo

Treatment response using a tumor-informed circulating DNA test (TIctDNA) comparing with radiologic outcomes in non-small cell lung cancer (NSCLC)

October 18, 12:00 PM CEST | 1132P

Presenter: Floortje Backes, M.D.

Utility of circulating tumor DNA (ctDNA) dynamics for evaluating early treatment response in patients with recurrent/metastatic endometrial (rEC) and recurrent/platinum-resistant ovarian cancer (rPROC)

October 18, 12:00 PM CEST | 2609P

Presenter: Arnab Basu, MBBS, MPH, FACP, M.D.

Clinical Performance of a Tumor-Informed Whole Genome-Based (WGS) ctDNA Assay for Recurrence Detection and Treatment Response Monitoring in Localized and Advanced/Metastatic Renal Cell Carcinoma (RCC)

October 19, 12:00 PM CEST | 764P

Presenter: Masaaki Miyo, M.D., Ph.D.

Association of ultrasensitive whole genome sequencing (WGS)-based tumor-informed molecular residual disease (MRD) detection with lymph node metastasis (LNM) after local excision of pathological T1 colorectal cancer: Results from DENEB, a CIRCULATE-Japan GALAXY substudy

October 19, 2:45 PM CEST | 734MO (Mini Oral Presentation)

Presenter: Yoshiaki Nakamura, M.D., Ph.D.

Performance of a blood-based, early cancer detection (ECD) screening test for colorectal cancer (CRC) in cell-free (cf)DNA

October 19, 2:50 PM CEST | 732MO (Mini Oral Presentation)

Presenter: Emerick Osterlund, M.D., Ph.D.

Circulating tumor DNA (ctDNA) clearance and correlation with outcome in the INTERCEPT colorectal cancer (CRC) study

October 19, 12:00 PM CEST | 823P

Presenter: Kozo Kataoka, M.D.

A Phase II Study of mFOLFOXIRI Following Metastasectomy in Oligometastatic Colorectal Cancer: (FANTASTIC)

October 19, 3:40 PM CEST | LBA 31 (Oral Presentation)

Presenter: Yara L. Verschoor

Neoadjuvant immunotherapy induces immune activation and responses in MMR-proficient colon cancers

October 20, 12:00 PM CEST | 620TiP

Presenter: Benjamin Verret, M.D.

HEROES: De-escalation of anti-HER2 therapies in HER2-positive metastatic breast cancer with long-term persistent response and undetectable minimal residual disease in circulating tumor DNA

October 20, 12:00 PM CEST | 354P

Presenter: Adrian Lee, Ph.D.

Hormonal and immune mediators of resistance to primary endocrine therapy

October 20, 12:00 PM CEST | 336P

Presenter: Arielle J. Medford, M.D.

Circulating tumor DNA detection in stage 1 HER2 positive and triple negative breast cancer (SAFE-DE)

October 20, 4:30 PM CEST | LBA 8 (Oral Presentation)

Presenter: Thomas B. Powles, MBBS, MRCP, M.D.

IMvigor011: a Phase 3 trial of circulating tumour (ct)DNA-guided adjuvant atezolizumab vs placebo in muscle-invasive bladder cancer

Notes

Tecentriq® (atezolizumab) is a registered trademark of Genentech, a member of the Roche Group.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 300 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Forward-Looking Statements

All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera’s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.

More News From Natera, Inc.

Sound Income Strategies, LLC disclosed the sale of 177,473 shares of Hercules Capital (HTGC -2.02%) for an estimated $3.40 million in an SEC filing dated October 10, 2025.

What HappenedAccording to a filing with the Securities and Exchange Commission dated October 10, 2025, Sound Income Strategies, LLC reduced its stake in Hercules Capital by 177,473 shares during the quarter ending on September 30, 2025. The estimated transaction value, based on the average closing price for the quarter, was approximately $3.40 million. Following the sale, the fund reported holding 2,752,867 shares at quarter-end.

What Else to KnowThis reduction in the Hercules Capital position now accounts for 2.6% of Sound Income Strategies, LLC's reportable U.S. equity assets.

Top holdings after the filing:

NYSE:TSLX: $50.57 million (2.8% of AUM) as of September 30, 2025NASDAQ:ARCC: $47.33 million (2.6% of AUM) as of September 30, 2025NYSE:HTGC: $46.96 million (2.6% of AUM) as of September 30, 2025NASDAQ:GBDC: $45.58 million (2.5% of AUM) as of September 30, 2025UNK:SHYG: $42.91 million (2.4% of AUM) as of September 30, 2025As of October 9, 2025, shares were priced at $17.06, down 15.17% over the past year. Hercules Capital stock has underperformed the S&P 500 by 23.78 percentage points over the past year.

Company OverviewMetricValueRevenue (TTM)$504 millionNet Income (TTM)$257 millionDividend Yield11.26%Price (as of market close 2025-10-09)$17.06Company SnapshotHercules Capital provides venture debt, senior secured loans, and growth capital, primarily to privately held, venture capital-backed companies across technology, life sciences, and sustainable energy sectors.

The company targets emerging and growth-stage companies in the United States, with a focus on technology, life sciences, and energy technology firms seeking flexible financing solutions.

It serves a customer base of innovative, high-growth companies that require customized funding to support expansion and liquidity needs.

Hercules Capital is a leading provider of specialized financing solutions for innovative, high-growth companies, leveraging structured debt and equity investments to support expansion and liquidity needs. Its competitive advantage lies in deep sector expertise and the ability to deliver customized funding to underserved segments of the venture ecosystem.

Foolish takeSound Income Strategies trimmed its stake in Hercules Capital during the third quarter, selling nearly $3.5 million worth of Hercules stock. That may seem like a very large sale -- and it is by most retail standards -- but for a investment advisory firm like Sound Income, which has more than $1.8 billion in assets under management, this sale represents just an adjustment.

As for Hercules, the stock has endured a difficult 12 months. Shares have posted a total return of (6.2%), which is far worse than the S&P 500 over that same period, which posted a total return of 14.2%. The company, which operates as a key lender to the venture capital ecosystem, appears to have fallen out of favor with the broader market, with shares falling by nearly 15% in the last month alone.

Nonetheless, the average investor shouldn't get the wrong idea about this sale. As of September 30, Sound Income retains more than 2.7 million shares, making Hercules its third-largest position. In other words, this looks like institutional noise, rather than a significant directional call by the fund managers.

Glossary13F AUM: The total value of assets under management reported by institutional investment managers in quarterly SEC Form 13F filings.
AUM (Assets Under Management): The total market value of all investments managed by a fund or investment firm.
Venture debt: Loans provided to early-stage, venture capital-backed companies, often as an alternative or supplement to equity financing.
Senior secured loans: Loans backed by collateral and given repayment priority over other debts if the borrower defaults.
Growth capital: Funding provided to mature companies to expand operations, enter new markets, or finance significant acquisitions.
Dividend yield: Annual dividend income expressed as a percentage of the current share price.
Trailing: Refers to performance or data measured over a past period, often the previous 12 months.
TTM: The 12-month period ending with the most recent quarterly report.
Structured debt: Customized loan arrangements with specific terms, often including features like warrants or convertible options.
Liquidity needs: The requirement for cash or easily accessible funds to meet short-term obligations or opportunities.
Venture capital-backed companies: Firms that have received investment funding from venture capital firms to support growth and development.
Customized funding: Tailored financing solutions designed to meet the unique needs of specific companies or situations.

Jake Lerch has positions in Ares Capital. The Motley Fool has positions in and recommends Sixth Street Specialty Lending. The Motley Fool has a disclosure policy.

A Samsung Electronics logo and a computer motherboard appear in this illustration taken August 25, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

SummaryCompaniesSamsung Q3 profit forecast 10.1 trillion won, highest Q3 profit since 2022Profit boosted by conventional memory chips backed by server demandMemory chip gains to offset weaker HBM salesAnalysts warn of China's rare earths curbs, tariff risks despite AI chip dealsQ3 preliminary results expected on Tuesday, October 14SEOUL, Oct 13 (Reuters) - Samsung Electronics

(005930.KS), opens new tab is expected to post its highest third-quarter profit since 2022, driven by higher memory chip prices supported by server demand as customers rebuild inventories, analysts' estimates showed.

The world's biggest maker of memory chips is projected to report an operating profit of 10.1 trillion won ($7.11 billion) for the July-September period, according to LSEG SmartEstimate from 31 analysts, which is weighted toward those who are more consistently accurate. This would be up 10% from a year earlier.

Sign up here.

Analysts attributed the recovery mainly to better conventional memory chip pricing, which would offset weaker sales volumes of high-bandwidth memory (HBM) chips as Samsung has yet to supply its latest HBM products to Nvidia

(NVDA.O), opens new tab.

HBM chips, critical for artificial intelligence (AI) development, are designed to reduce power consumption and process large datasets by stacking chips vertically.

Analysts said demand for memory chips, particularly from hyperscalers and AI-related investments for services such as ChatGPT, have put more workload on general servers, thus boosting conventional memory chip prices.

Prices of some DRAM chips, widely used in servers, smartphones and PCs, jumped 171.8% in the third quarter from a year earlier, according to TrendForce data.

While Samsung's conventional memory business performed well, analysts said delays in supplying its latest 12-layer HBM3E chips to Nvidia have hurt its profit and share price.

Rivals SK Hynix

(000660.KS), opens new tab and Micron

(MU.O), opens new tab have gained more from AI-driven demand, while Samsung's exposure to China, where advanced chip sales are restricted by the United States, has constrained its growth.

Analysts said market sentiment toward Samsung's shares and chip business, including both memory and contract chip manufacturing, is expected to improve as it secures supply deals with major customers such as OpenAI and Tesla

(TSLA.O), opens new tab.

Samsung shares have risen more than 43% following its announcement of a chip supply deal with Tesla in July.

During OpenAI CEO Sam Altman's visit to South Korea earlier this month, Samsung, SK Hynix and OpenAI announced partnerships to supply advanced memory chips to the Stargate project.

The AI chip deal between OpenAI and AMD

(AMD.O), opens new tab, one of Samsung's major HBM customers, would also benefit Samsung, said Ryu Young-ho, a senior analyst at NH Investment & Securities.

Ryu added that Samsung's $16.5 billion foundry deal with Tesla has lifted expectations that Samsung's struggling contract chip manufacturing business could win more orders from major tech firms if the company delivers the project as planned.

While recent AI-driven supply deals signal a positive outlook for Samsung, analysts cautioned that uncertainties remain, including potential U.S. tariffs on chips and China's tightened export controls on rare earth materials used in advanced chips and manufacturing equipment.

In September, Micron said it expects to sell out all of its HBM chips for calendar year 2026 in the coming months due to strong demand.

Samsung will announce its estimates on revenue and operating profit on Tuesday, with full results due later this month.

($1 = 1,420.1000 won)

Reporting by Heekyong Yang; Editing by Jacqueline Wong

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Oct 12, 2025 at 20:37 // Price

Coinidol.com: the price of Bitcoin Cash (BCH) has broken out of its sideways trend, falling below the lower price range of $530.

Bitcoin Cash price long-term analysis: bearish

Since August 12, BCH has been trading between the $530 support and below the $640 resistance, as Coinidol.com wrote. The cryptocurrency reached a low of $474 before recovering.

Today, BCH reversed upwards to reach a high of $540 before pulling back. Buyers are struggling to push the price above the $530 level, which has now become a resistance. BCH is currently trading above the $475 support and below the $540 peak. On the positive side, BCH will resume its upward trend if buyers can sustain the price above the $530 resistance. However, a further decline in the cryptocurrency is unlikely.

Technical Indicators

Key Resistance Zones: $600, $650, $700

Key Support Zones: $500, $450, $400

Bitcoin Cash indicator reading

A long candlestick has broken above the $475 level, indicating strong buying pressure near the $475 support. The price bars are below the horizontal moving average lines. The 21-day SMA is sliding down towards the 50-day SMA support.

BCH/USD daily chart - October 11, 2025

What is the next direction for BCH/USD?

After its decline, BCH has recovered above the $500 support level. The altcoin is currently trading above the $500 support but below the $540 resistance. The $540 barrier is hindering the upward trend. Doji candlesticks have appeared, indicating that price movement has stalled.

BCH/USD 4-hours chart - October 11, 2025

Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement by CoinIdol.com. Readers should do their research before investing in funds.

Dogecoin (DOGE) has been showing steady gains over recent months, and many traders are now asking: is it too late to buy? According to three widely followed analysts, the technical setup for DOGE remains constructive, provided key support levels hold.

Changpeng Zhao (CZ) jumped to the defense of the BNB token of the BNB Chain and Binance, as some posts have begun to imply foul play as to how the token has defied the negative price influence that swept through the market.

While Ethereum laid down the groundwork for smart contracts,21Shares found that Solana's speed and cheap transactions are driving adoption across a broader spectrum, faster than Ethereum.

Solana’s revenue engine has matured at a pace few in the industry could have anticipated, and has now clearly surpassed Ethereum’s early growth trajectory.

From meme coin mania, DeFi, AI, and RWAs, Solana has managed to capture several on-chain revenue streams that Ethereum couldn’t monetize early, a new report suggests.

Solana’s Early Growth Curve
According to 21Shares, the blockchain generated roughly $2.85 billion in revenue between October 2024 and September 2025, after averaging nearly $240 million per month.

Peaks during periods of intense trading activity were found to be more than $600 million, with January 2025 marking the absolute high point at $616 million. This surge was driven largely by meme coin mania, including coins like Trump Coin. Even after the speculative frenzy cooled, Solana’s monthly revenues have remained in the $150 million-$250 million range. Such sustained figures demonstrated that the chain’s success “is not merely a speculative flash in the pan.”

A closer look at the revenue composition reveals a highly diversified ecosystem. Trading applications such as Photon and Axiom contributed $1.12 billion, or 39% of the total, by facilitating faster swaps, advanced execution, and high-frequency activity.

Beyond trading, Solana’s infrastructure supports a broad spectrum of DeFi, AI, DePin, and tokenized real-world asset applications. Its architecture, capable of thousands of transactions per second at sub-$0.01 costs, has effectively transformed Solana into a 24/7, global “on-chain Nasdaq,” which has helped it rival long-established Web 2 companies like Palantir ($2.8 billion in 2024) and Robinhood ($2.95 billion) in annual revenue.

Perspective Check
The contrast with Ethereum during its formative years couldn’t be more obvious. Between 2019 and 2020, roughly four to five years after Ethereum’s launch, monthly revenue averaged less than $10 million, which is less than 5% of what Solana now produces on a monthly basis.

You may also like:

Ethereum Foundation Assembles 47 Experts for New Privacy Initiative

BNB Meme Coin Frenzy Creates Overnight Millionaires and Costly Mistakes

Ethereum Could Triple to $13,000 This Cycle If History Repeats, Analysts Say

In peak months, Solana’s revenue has outpaced Ethereum’s early numbers by more than 50x. While Ethereum’s growth was constrained by congestion and modest gas fee revenue in a nascent DeFi ecosystem, Solana has leveraged high throughput and low fees to monetize a broader range of activity much earlier in its lifecycle.

Daily active addresses on Solana now consistently hit 1.2-1.5 million, compared to Ethereum’s 400,000-500,000 during its early years.

Solana’s revenue growth has not been linear. 21Shares found that just two years ago, between October 2022 and September 2023, total network revenue stood at a mere $13 million, which can be attributed to early skepticism amid outages and market turbulence. The 220x increase over the past 12 months, however, was a shift from experimental blockchain to a commercially viable ecosystem.

Soon after, institutional interest followed suit. Currently, over $3 billion in SOL is held on public company balance sheets, and multiple treasury initiatives are underway from firms including Forward Industries, Pantera Capital, and Brera Holdings.

Disclaimer

Disclaimer: Blockchain.news provides content for informational purposes only. In no event shall blockchain.news be responsible for any direct, indirect, incidental, or consequential damages arising from the use of, or inability to use, the information provided. This includes, but is not limited to, any loss or damage resulting from decisions made based on the content. Readers should conduct their own research and consult professionals before making financial decisions.

On Sunday, bitcoin ( BTC) climbed to an intraday high of $114,777, marking a nearly 2.7% rebound in 24 hours. The surge reflects renewed confidence and heightened market activity as crypto traders react to shifting economic signals and buying momentum.

Solana (SOL) traders are projecting an uphill run for the asset, driven by the adoption of massive corporate treasuries over the past few weeks. The dominant trend has seen institutional giants and smaller firms pick up crypto assets, diversifying their balance sheets to boost financials. While Bitcoin remains the leader, altcoins like Solana and Ethereum (ETH) have garnered significant institutional support.

Helius Plans 5% Solana Acquisition
Solana digital asset treasury firm Helius plans to purchase 5% the supply valued at over $6 billion. This comes amid increased plans to boost its asset reserves before the end of the year. The healthcare technology company moved towards the asset class and secured $500 million last month.

In a recent interview, Joseph Chee, the company’s Solana treasury, noted that the new purchase will be made after it meets regulatory and capitalization requirements. The company’s goal is to bag as much as 5% of Solana’s supply within six months. It should be noted that for such a deal to pull through, Solana must be shown to meet suitability criteria that meet public interests.

Zhu Junwei, the executive chairman of Helius Solana Company (HSDT), explained that the strategy is a bridge for the flow of funds. He pointed out that the success of a treasury strategy requires proper management to boost financials.

“Financing at a cost of capital lower than one to one, that is, getting something originally worth 100 yuan for 200 yuan, is beneficial to shareholders, and your cryptocurrency per share will always increase,” he added. 

Advertisement
 

This year, traditional firms adopting Solana and other assets have surged, triggering higher prices in the market. Wider sentiments are also at a record level after the market cap broke the $4 trillion mark. A major catalyst for renewed Solana investment is its transaction speed and decentralized finance (DeFi) ecosystem. As more funds flow, bull projects an upward momentum to new highs. 

At the time of writing, Solana trades at $196, a 56% growth over the past year, although monthly trading remains almost sideways. Bulls are also keen on anticipated spot SOL ETFs in the United States to create a new investment window. Like Bitcoin, altcoin ETFs are expected to drive traditional capital to the asset class. Overall, while analysts predict a strong end to Q4 2025, heavy inflows observed in recent weeks could potentially attract long-term whales.

Tether CEO Paolo Ardoino: ‘Bitcoin and Gold Will Outlast Any Other Currency’Paolo Ardoino’s latest comment about bitcoin and gold echoes Tether’s policy of buying BTC with profits and building up gold exposure. Oct 12, 2025, 8:48 p.m.

Tether CEO Paolo Ardoino said in a post on X on Sunday that "Bitcoin and Gold will outlast any other currency," a minimalist line that aligns with how the stablecoin issuer has positioned parts of its reserves over the past two years.

On May 17, 2023, Tether said it would regularly allocate up to 15% of net realized operating profits to purchase bitcoin for reserves, adding BTC to surplus rather than using it to back circulating USDT one-for-one. The company framed the move as strengthening its balance sheet with a long-term store of value.

STORY CONTINUES BELOW

BTC and gold as parallel pillarsGold sits alongside bitcoin in that mix.

Tether issues tether gold (XAUt), a token backed by allocated bars, and said on July 24 that more than 7.66 tons of metal backed outstanding tokens as of June 30, 2025. Separately, as CoinDesk reported on Sept. 5, 2025, citing the Financial Times, Tether has held talks to invest across the gold value chain — from mining and refining to royalties — as part of a broader diversification push.

Ardoino has grouped the assets rhetorically before. On Sept. 7, he referenced bitcoin, gold and land as hedges and later dismissed suggestions that Tether sold BTC to accumulate gold, saying the firm remained committed to growing its bitcoin position.

Today's eight-word post is less a policy shift than a restatement — bitcoin as a strategic asset added with profits, and gold as a parallel pillar via tokenization and potential upstream investments — while most reserves remain in liquid instruments such as U.S. Treasurys per attestations. The next reserve report, expected late this month or early next month, will show whether allocations to BTC and gold have changed.

As of Sunday, 8:10 p.m. UTC, the U.S. dollar index (DXY) was down 8.88% year to date, while bitcoin and gold — BTC-USD and XAU-USD — were up 22.79% and 52.91%, respectively, according to MarketWatch.

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

Mais para você

Total Crypto Trading Volume Hits Yearly High of $9.72T

9 de set. de 2025

Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025

O que saber:

Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025Gate exchange emerged as major player with 98.9% volume surge to $746 billion, overtaking Bitget to become fourth-largest platformOpen interest across centralized derivatives exchanges rose 4.92% to $187 billionView Full Report

Mais para você

Altcoins Cratered in Oct. 10 Crypto Flash Crash as Bitcoin Held Up, Wiston Capital Says

há 3 horas

Wiston Capital's Charlie Erith says a leverage cascade drove the Oct. 10 break, with altcoins hit hardest, and lays out the signals he will track before adding risk.

O que saber:

About $560 billion (13.1%) has come off total crypto market value since Oct. 6, Wiston Capital Founder Charlie Erith says.Tokens excluding bitcoin, ether and stablecoins fell about 33% in roughly 25 minutes during the break, alongside approximately $18.7 billion in liquidations, he says.He is watching bitcoin’s 365-day EMA, bitcoin dominance, Strategy’s trend and the VIX, while staying invested but not levered.Leia a história completa

Journalist

Posted: October 13, 2025

Key Takeaways
Did Cardano whales buy the dip after the crash?
Wallets holding 10M-100M ADA rose sharply between October 10-11.

What does the derivatives data say about trader sentiment?
Funding rates flipped positive after the crash, so traders are cautiously turning bullish again.

Cardano [ADA] steadied on the 11th of October after a sharp 20% sell-off, as whale investors bought the dip during broader market turbulence.

In fact, large holders accumulated millions of ADA during the downturn, helping to limit further losses and bringing in early signs of a possible recovery.

Cardano bounces back after flash liquidation
In the hours following the crypto market’s record $19 billion liquidation event, ADA saw heavy selling pressure that pushed the price to a low near $0.62.

Source: TradingView

The short-term RSI was around 45, while the Chaikin Money Flow (CMF) went into positive territory; subtle accumulation. As whales stepped in, the coin stabilized around $0.645, beginning a tentative recovery.

Early signs suggested ADA may attempt to reclaim momentum, but the short-term market may remain cautious following the historic sell-off.

Whales come back
Between the 10th and 11th of October, Santiment data showed a sharp rise in ADA holdings among wallets holding between 10 million and 100 million tokens, jumping from roughly 466 to 472 wallets.

Source: Santiment

This uptick in large-holder addresses came right after the market-wide liquidation, so perhaps whales took advantage of the crash to accumulate discounted ADA.

Rebeca Moen
Oct 12, 2025 19:11

XRP price prediction points to $3.25-$3.62 targets within 4 weeks as SEC ETF decisions approach, despite current bearish momentum at $2.53 requiring breakout above $3.00.

XRP Price Prediction Summary
• XRP short-term target (1 week): $2.85-$3.10 (+12-22% from current $2.53)
• Ripple medium-term forecast (1 month): $3.25-$3.62 range (+28-43% upside potential)
• Key level to break for bullish continuation: $3.00 resistance
• Critical support if bearish: $2.31 daily low, then $2.00 major support

Recent Ripple Price Predictions from Analysts
The latest XRP price prediction consensus from major analysts shows a bullish tilt despite mixed technical signals. The Bit Journal presents the most aggressive Ripple forecast, targeting $3.30-$3.62 driven by anticipated SEC decisions on spot XRP ETFs between October 18-25. This high-confidence prediction aligns with Finance Magnates' technical analysis pointing to similar $3.25-$3.62 targets.

Changelly's more conservative XRP price prediction of $2.87-$3.25 reflects the current technical uncertainty, while contrarian voices like Long Forecast warn of potential decline to $2.00. The 74% spread between the most bullish ($3.62) and bearish ($2.00) predictions highlights the critical juncture XRP faces.

XRP Technical Analysis: Setting Up for Breakout Despite Bearish Momentum
Current Ripple technical analysis reveals a complex setup with conflicting signals. XRP trades at $2.53, positioned just 0.11 within the Bollinger Bands range, indicating proximity to the lower band at $2.45. This compressed position often precedes significant moves.

The RSI at 36.57 sits in neutral territory but leans oversold, suggesting potential for upward reversal. However, the MACD histogram at -0.0539 shows persistent bearish momentum, while the MACD line (-0.0986) remains below its signal line (-0.0447).

XRP's position below all major moving averages except the 200-day SMA ($2.58) confirms short-term weakness. The critical resistance cluster between $3.00-$3.19 (Bollinger upper band) represents the make-or-break level for any meaningful XRP price target achievement.

Trading volume of $660M on Binance indicates healthy liquidity, supporting the potential for significant moves when technical breakouts occur.

Ripple Price Targets: Bull and Bear Scenarios
Bullish Case for XRP
The primary bullish XRP price prediction scenario targets $3.25-$3.62 based on several converging factors. A breakout above $3.00 resistance would likely trigger momentum toward the Bollinger upper band at $3.19, followed by the analyst consensus range.

The ETF catalyst represents the strongest fundamental driver, with SEC decisions potentially unlocking institutional demand between October 18-25. Technical confirmation would require RSI pushing above 50 and MACD histogram turning positive.

Weekly resistance at $3.55 (52-week high) becomes the ultimate bull target, representing a 40% gain from current levels. This Ripple forecast assumes sustained volume above $800M daily.

Bearish Risk for Ripple
The bearish scenario for XRP price prediction centers on failure to hold $2.31 support, opening the path to $2.00 as Long Forecast suggests. A break below the 200-day SMA at $2.58 would intensify selling pressure.

MACD remaining in bearish territory and RSI failing to break 40 would confirm continued weakness. The ultimate downside XRP price target sits at $1.74, representing a 31% decline and testing the lower boundary of the analyst range.

Volume declining below $400M would signal diminishing interest and support the bearish Ripple technical analysis.

Should You Buy XRP Now? Entry Strategy
Current levels present a calculated opportunity for the aggressive Ripple forecast targeting $3.25+. Optimal entry points include:

Primary Entry Zone: $2.45-$2.53 (current level to Bollinger lower band)
Aggressive Entry: $2.31 breakdown with quick reversal
Conservative Entry: $2.85+ breakout confirmation above SMA-7

Risk Management:
- Stop-loss: $2.30 (below daily support)
- Position sizing: 2-3% of portfolio maximum
- Profit targets: 25% at $3.19, 50% at $3.45

The buy or sell XRP decision favors selective buying at current oversold levels, with strict risk management given the conflicting technical signals.

XRP Price Prediction Conclusion
The XRP price prediction for October 2025 targets $3.25-$3.62 within 3-4 weeks, supported by ETF catalyst expectations and oversold technical conditions. However, immediate breakout above $3.00 resistance remains essential for this Ripple forecast to materialize.

Confidence Level: Medium-High (70%) for reaching $3.25, Medium (55%) for $3.62 targets.

Key indicators to monitor:
- RSI breaking above 40 for momentum confirmation
- MACD histogram turning positive
- Volume sustaining above $600M daily
- SEC ETF decision timeline adherence

The prediction timeline centers on October 18-25 for catalyst-driven moves, with technical confirmation needed by October 20 to validate the bullish XRP price target scenario.

Image source: Shutterstock

xrp price forcast
xrp price prediction

Darius Baruo
Oct 12, 2025 19:23

Solana shows strong recovery potential with SOL price prediction pointing to $237-$244 targets. Technical analysis reveals oversold bounce opportunity from current $195.69 levels.

Solana has demonstrated remarkable resilience with a strong 9.48% daily surge, positioning SOL for a potential technical recovery that could deliver significant gains for positioned traders. Our comprehensive SOL price prediction analysis reveals compelling bullish catalysts emerging from oversold conditions.

SOL Price Prediction Summary
• SOL short-term target (1 week): $226-$233 (+15-19% from current levels)
• Solana medium-term forecast (1 month): $215-$244 range with bias toward upper bound
• Key level to break for bullish continuation: $213.43 (SMA 20 resistance)
• Critical support if bearish: $182.15 (Bollinger Band lower boundary)

Recent Solana Price Predictions from Analysts
The latest Solana forecast from multiple analytical sources presents an intriguing mixed picture that actually supports our bullish thesis. Changelly's aggressive SOL price target of $233.82 aligns closely with our technical projections, while AMB Crypto's $226.35 target represents a more conservative but achievable near-term objective.

The consensus clustering around the $220-$235 range validates our technical analysis, particularly given that these predictions emerged before SOL's recent 9.48% breakout move. The bearish outlier at $199 from 30rates.com appears increasingly unlikely given the current momentum shift and technical positioning.

Most significantly, these analyst predictions failed to account for the oversold bounce potential that our Solana technical analysis clearly identified through RSI and Bollinger Band positioning.

SOL Technical Analysis: Setting Up for Momentum Recovery
The technical landscape for Solana presents a compelling case for sustained upward movement. With SOL currently trading at $195.69, the token sits just 0.22 within the Bollinger Bands - indicating extreme oversold conditions that historically precede strong bounces.

The RSI reading of 42.35 positions SOL in neutral territory with significant room for expansion before reaching overbought levels. This provides a technical runway for price appreciation without immediate momentum concerns. The negative MACD histogram of -4.3899 represents residual bearish momentum that's rapidly diminishing as evidenced by today's strong price action.

Volume confirmation stands robust at $1.2 billion in 24-hour trading, providing the liquidity foundation necessary for sustained price moves. The proximity to the Bollinger Band lower boundary at $182.15 creates a compelling risk-reward setup with clear technical support levels.

Solana Price Targets: Bull and Bear Scenarios
Bullish Case for SOL
Our primary SOL price prediction targets the $237-$244 zone within 2-3 weeks, representing a 21-25% upside potential from current levels. This target zone aligns with the Bollinger Band upper boundary at $244.71 and immediate resistance at $237.79.

The technical pathway requires SOL to reclaim the SMA 20 at $213.43, which would trigger momentum acceleration toward the SMA 7 at $209.14. Once these moving averages flip supportive, the path opens toward our primary target zone.

A breakout above $244 would shift our Solana forecast toward the strong resistance zone at $253.51, potentially reaching the 52-week high of $247.50 within the month.

Bearish Risk for Solana
The primary risk to our bullish SOL price prediction centers on a breakdown below $182.15, which would invalidate the oversold bounce thesis. Such a move would target the immediate support at $168.79, representing a 14% downside risk.

Critical warning signals would include RSI breaking below 35 and daily volume declining below $800 million, indicating institutional selling pressure. The pivot point at $188.29 serves as our key invalidation level for the bullish scenario.

Should You Buy SOL Now? Entry Strategy
Based on our technical analysis, current levels present an attractive buy or sell SOL decision favoring the long side. Aggressive traders can initiate positions at current levels around $195-$197, while conservative investors should wait for a pullback to $188-$190.

Recommended stop-loss placement sits at $180, providing a tight 8% risk parameter while allowing room for normal volatility. Position sizing should reflect the moderate confidence level in this prediction, suggesting 2-3% portfolio allocation for risk-conscious traders.

The optimal entry strategy involves scaling into positions, with 50% allocation at current levels and 50% reserved for potential dips toward $188. This approach maximizes the probability of capturing the predicted move while managing downside exposure.

SOL Price Prediction Conclusion
Our comprehensive analysis yields a medium-high confidence SOL price prediction targeting $237-$244 within 2-3 weeks, representing 21-25% upside potential. The technical setup combines oversold conditions, volume confirmation, and clear resistance targets to create a compelling risk-reward opportunity.

Key indicators to monitor include RSI momentum above 45, sustained volume above $1 billion, and most critically, SOL's ability to reclaim and hold the $213.43 level. Failure to achieve this within 5-7 trading days would require reassessment of the bullish thesis.

The timeline for this Solana forecast extends through early November 2025, with primary targets expected within the next 15-20 trading sessions based on historical volatility patterns and current technical momentum.

Image source: Shutterstock

sol price forcast
sol price prediction

Timothy Morano
Oct 12, 2025 19:35

MATIC price prediction suggests potential 105% upside to $0.78 target within 30 days, but technical indicators show mixed signals requiring careful risk management.

MATIC Price Prediction Summary
• MATIC short-term target (1 week): $0.42-$0.45 (+11-18%) - Testing SMA 20 resistance
• Polygon medium-term forecast (1 month): $0.55-$0.78 range (+45-105%) if momentum shifts
• Key level to break for bullish continuation: $0.58 - Strong resistance that unlocks higher targets
• Critical support if bearish: $0.35 - Break below triggers deeper correction to $0.33

Recent Polygon Price Predictions from Analysts
The latest MATIC price prediction consensus reveals a cautiously optimistic outlook despite current technical headwinds. Recent analyst forecasts show significant variance in timeframes and targets:

PricePredictions.com's conservative $0.804742 short-term target aligns closely with our technical resistance analysis at $0.78-$0.80. Their medium confidence rating reflects the challenging current setup, where MATIC trades below all major moving averages except the 7-day SMA.

More aggressive predictions include PriceForecastBot's $1.20834 medium-term target and CoinCodex's ambitious $1.751138 long-term forecast suggesting a 339% annual return. While these Polygon forecast projections appear optimistic given current bearish momentum indicators, they align with historical recovery patterns following oversold conditions.

The consensus view centers around initial recovery to $0.78-$0.80, making this our primary MATIC price target for the next 30 days.

MATIC Technical Analysis: Setting Up for Potential Reversal
Current Polygon technical analysis reveals a classic oversold setup with mixed momentum signals. MATIC's RSI at 38.00 sits in neutral territory but approaching oversold levels, historically preceding bounce attempts.

The MACD histogram at -0.0045 shows persistent bearish momentum, but the narrowing gap between MACD (-0.0246) and signal line (-0.0202) suggests potential bullish divergence formation. This technical pattern often precedes trend reversals when combined with oversold RSI conditions.

Bollinger Bands positioning provides crucial insight - MATIC's %B at 0.29 indicates price trading in the lower third of the band, with room for mean reversion toward the middle band at $0.43. The 24-hour trading volume of $1,074,371 on Binance remains relatively light, suggesting accumulation rather than distribution.

Critical resistance cluster exists at $0.42-$0.45 (SMA 20 and SMA 50), where previous support has now turned resistance. A decisive break above this zone would shift the intermediate outlook from bearish to neutral.

Polygon Price Targets: Bull and Bear Scenarios
Bullish Case for MATIC
Primary Target: $0.78 (105% upside) - This MATIC price target represents the convergence of multiple technical factors including the 0.618 Fibonacci retracement from the recent decline and the lower boundary of the previous trading range.

Extended Target: $1.20 (215% upside) - Achievable if broader crypto market sentiment improves and MATIC reclaims the SMA 200 at $0.69. This level coincides with PriceForecastBot's medium-term prediction.

Catalyst Requirements: Break above $0.58 resistance with volume expansion above 2 million daily, RSI reclaiming 50+ territory, and MACD histogram turning positive.

Bearish Risk for Polygon
Immediate Risk: $0.35 support failure leads to $0.33 (13% downside) - This represents the 52-week low and final technical support before acceleration lower.

Extended Downside: $0.28-$0.30 zone (21-26% downside) - Previous 2023 lows that could be retested if broader market conditions deteriorate.

Risk Triggers: Daily close below $0.35, RSI breaking below 30 into oversold territory, and continued MACD histogram expansion into negative territory.

Should You Buy MATIC Now? Entry Strategy
Based on current Polygon technical analysis, a staged accumulation approach appears most prudent rather than aggressive buying.

Conservative Entry: $0.35-$0.37 zone with 25% position size - This provides favorable risk/reward with tight stop-loss below $0.33 (6% risk) targeting $0.45 initial resistance (22% reward).

Aggressive Entry: Current levels $0.38-$0.39 with 15% position size - Higher risk but captures potential immediate bounce toward SMA 20 at $0.43.

Stop-Loss Strategy: Hard stop below $0.33 (52-week low) with trailing stop adjustment to $0.37 once price reaches $0.45.

Position Sizing: Maximum 5-7% portfolio allocation given high volatility (ATR 14 at $0.03) and uncertain broader market conditions.

The verdict on buy or sell MATIC currently favors cautious accumulation on weakness rather than aggressive buying, given mixed technical signals and proximity to critical support.

MATIC Price Prediction Conclusion
Our MATIC price prediction maintains a cautiously bullish outlook with 30-day target of $0.78 (105% upside potential) and medium confidence level. However, this forecast depends heavily on holding the $0.35 support level and broader cryptocurrency market stability.

Key confirmation signals to monitor:
- RSI reclaiming 45+ level indicating momentum shift
- MACD histogram turning positive for first time since early October
- Daily close above $0.42 (SMA 20) with volume expansion
- Break above $0.58 resistance for acceleration toward $0.78 target

Invalidation triggers:
- Daily close below $0.35 support
- RSI falling below 30 into deeply oversold territory
- Volume spike accompanying price breakdown

Timeline: 15-30 days for initial $0.45-$0.50 recovery, 30-45 days for primary $0.78 target assuming technical conditions improve. This Polygon forecast requires active monitoring as crypto markets remain highly volatile and subject to rapid sentiment shifts.

Image source: Shutterstock

matic price forcast
matic price prediction

Darius Baruo
Oct 12, 2025 19:47

AVAX price prediction suggests a recovery to $31-35 range within a month as current oversold conditions near $22.92 create buying opportunity despite bearish MACD signals.

Avalanche (AVAX) presents a compelling technical setup at current levels, trading at $22.92 with mixed signals that could determine its next major move. Our comprehensive AVAX price prediction analysis reveals both immediate challenges and medium-term opportunities for the Layer-1 blockchain token.

AVAX Price Prediction Summary
• AVAX short-term target (1 week): $26.50 (+15.6%) - Initial resistance test
• Avalanche medium-term forecast (1 month): $31.00-$35.00 range (+35-53% upside)
• Key level to break for bullish continuation: $28.84 (SMA 20 resistance)
• Critical support if bearish: $22.24 (Bollinger Band lower support)

Recent Avalanche Price Predictions from Analysts
The latest analyst predictions show remarkable consistency in bullish sentiment despite current price weakness. Changelly's progressive AVAX price prediction series demonstrates increasing confidence, with targets rising from $30.81 to $31.10 over recent days - all suggesting immediate upside potential of 35-36% from current levels.

More aggressive forecasts paint an even rosier picture. PricePredictions.com's $92.10 medium-term target represents a stunning 302% potential gain, while PriceForecastBot's AI-driven analysis points to $41.70 long-term, indicating 82% upside. This Avalanche forecast consensus suggests strong institutional confidence in the token's recovery potential.

The convergence around the $30-31 price range for short-term targets provides a clear AVAX price target for near-term recovery expectations, supported by technical analysis indicating oversold conditions.

AVAX Technical Analysis: Setting Up for Bullish Reversal
Current Avalanche technical analysis reveals a classic oversold setup with multiple indicators suggesting an imminent bounce. The RSI at 35.31 sits in neutral territory but closer to oversold levels, while the Bollinger Bands position at 0.0514 shows AVAX hugging the lower band - historically a bullish reversal signal.

The MACD histogram at -1.1376 presents the primary bearish concern, indicating continued negative momentum. However, this divergence between price action near support and momentum indicators often precedes trend reversals. The daily ATR of $3.18 suggests adequate volatility for meaningful moves in either direction.

Volume analysis shows robust trading activity at $150.6 million, indicating institutional interest despite the price decline. This volume profile supports the potential for a sustained move once directional clarity emerges.

Avalanche Price Targets: Bull and Bear Scenarios
Bullish Case for AVAX
The primary bullish scenario targets the $31-35 range within 4 weeks, aligning with analyst consensus. Initial resistance at the SMA 20 ($28.84) must break for continuation to the SMA 7 ($25.83) retest, followed by the critical $28.84 level.

Breaking above $28.84 opens the path to $31.10 (Changelly's target) and potentially the 52-week high region near $35.19. The Bollinger Bands upper band at $35.44 represents the maximum bullish extension for this cycle.

Technical catalysts supporting this Avalanche forecast include RSI divergence formation, potential MACD histogram bottoming, and strong support holding at current levels.

Bearish Risk for Avalanche
The bearish scenario activates if AVAX breaks below the crucial $22.24 Bollinger Band lower support. This breakdown could trigger a cascade to the pivot point level, with ultimate support at $8.52 - though such extreme downside appears unlikely given current market structure.

Immediate bearish confirmation would come from sustained trading below $22.00, accompanied by increasing volume and RSI breaking below 30. The 52-week low at $16.04 represents intermediate downside risk if broader market conditions deteriorate.

Should You Buy AVAX Now? Entry Strategy
Current levels present an attractive entry opportunity for the AVAX price prediction scenario. Optimal entry zones exist between $22.50-$23.50, with tight stop-losses below $21.50 to limit downside risk.

A more conservative approach involves waiting for initial resistance break above $25.00, confirming bullish momentum before entry. This strategy sacrifices some upside but reduces downside risk significantly.

Position sizing should reflect the mixed technical picture - consider 50% allocation at current levels with remaining 50% reserved for potential dip below $21.00 or breakout above $25.00 confirmation.

AVAX Price Prediction Conclusion
Our analysis suggests a medium confidence bullish AVAX price prediction targeting $31-35 within 4 weeks, representing 35-53% upside potential. The combination of oversold technical conditions, analyst consensus around $30+ targets, and strong support levels creates a favorable risk-reward setup.

Key indicators to monitor include MACD histogram divergence development, RSI bounce from current levels, and volume confirmation on any upward moves. The critical timeline spans the next 7-10 days for initial momentum confirmation.

The decision to buy or sell AVAX ultimately depends on risk tolerance, but current technical positioning favors patient accumulation with proper risk management over the next month.

Image source: Shutterstock

avax price forcast
avax price prediction

Disclaimer

Disclaimer: Blockchain.news provides content for informational purposes only. In no event shall blockchain.news be responsible for any direct, indirect, incidental, or consequential damages arising from the use of, or inability to use, the information provided. This includes, but is not limited to, any loss or damage resulting from decisions made based on the content. Readers should conduct their own research and consult professionals before making financial decisions.

Disclaimer

Disclaimer: Blockchain.news provides content for informational purposes only. In no event shall blockchain.news be responsible for any direct, indirect, incidental, or consequential damages arising from the use of, or inability to use, the information provided. This includes, but is not limited to, any loss or damage resulting from decisions made based on the content. Readers should conduct their own research and consult professionals before making financial decisions.

Lawrence Jengar
Oct 12, 2025 20:05

BCH price prediction shows potential 15% rally to $615 resistance level, though bearish MACD signals caution. Critical $477 support holds key to Bitcoin Cash forecast.

BCH Price Prediction: Bitcoin Cash Eyes $615 Breakout Despite Bearish Momentum
Bitcoin Cash has demonstrated remarkable resilience with an 8.02% surge in the past 24 hours, trading at $541.70 as of October 12, 2025. Despite this impressive recovery, mixed technical signals present a complex picture for our BCH price prediction analysis moving forward.

BCH Price Prediction Summary
• BCH short-term target (1 week): $615 (+13.5% upside potential)
• Bitcoin Cash medium-term forecast (1 month): $580-$650 range with bias toward upper end
• Key level to break for bullish continuation: $615.30 immediate resistance
• Critical support if bearish: $477.70 (24-hour low and strong support confluence)

Recent Bitcoin Cash Price Predictions from Analysts
The cryptocurrency analysis community has been notably quiet on BCH price prediction commentary over the past three days, creating an information vacuum that often precedes significant price movements. This absence of analyst coverage suggests Bitcoin Cash may be flying under the radar, potentially setting up for a surprise breakout that catches the market off-guard.

Without recent analyst predictions to reference, our Bitcoin Cash forecast relies heavily on technical analysis and historical price patterns. The lack of widespread attention could work in BCH's favor, as retail and institutional FOMO often drives price action once a clear technical breakout occurs.

BCH Technical Analysis: Setting Up for Resistance Test
The current Bitcoin Cash technical analysis reveals a fascinating dichotomy between price action and momentum indicators. While BCH has surged 8.02% in 24 hours, the MACD histogram sits deeply negative at -6.5644, indicating underlying bearish momentum hasn't fully reversed.

The RSI reading of 43.72 places Bitcoin Cash in neutral territory, providing room for further upside without entering overbought conditions. This technical setup suggests our BCH price prediction of $615 remains achievable without triggering immediate selling pressure from momentum traders.

Bitcoin Cash currently trades within its Bollinger Bands at a 0.30 position, sitting closer to the lower band ($508.00) than the upper band ($621.27). This positioning typically indicates oversold conditions recovering toward equilibrium, supporting a continued move toward the middle band at $564.64.

Volume analysis shows healthy participation with $38.76 million in 24-hour Binance spot trading, providing sufficient liquidity to support the predicted price targets. The combination of strong volume and price recovery suggests institutional interest remains intact.

Bitcoin Cash Price Targets: Bull and Bear Scenarios
Bullish Case for BCH
The primary BCH price target in a bullish scenario targets the immediate resistance at $615.30, representing a 13.5% upside from current levels. A successful break above this level could trigger momentum toward the 52-week high of $624.40, just 1.5% higher.

For this bullish Bitcoin Cash forecast to materialize, BCH needs to maintain support above the $521.30 pivot point while the MACD histogram begins showing less negative readings. The key catalyst would be a decisive break above the $564.64 middle Bollinger Band, which currently acts as dynamic resistance.

Extended bullish targets place BCH at $650-$680 range if momentum accelerates beyond the 52-week high. However, this scenario requires broader cryptocurrency market support and increased adoption metrics for Bitcoin Cash.

Bearish Risk for Bitcoin Cash
The bearish scenario for our BCH price prediction centers around the critical $477.70 support level, which represents both the 24-hour low and strong technical support. A break below this level could trigger a swift decline toward the lower Bollinger Band at $508.00, though this would create an oversold condition.

More concerning would be a break below the $476.98 200-day simple moving average, which has provided crucial long-term support. Such a breakdown could target the $450-$420 range, representing a 17-22% decline from current levels.

The negative MACD histogram serves as the primary bearish indicator, suggesting underlying momentum hasn't fully shifted positive despite the recent price surge. Traders should monitor for MACD divergence if BCH approaches resistance levels.

Should You Buy BCH Now? Entry Strategy
Based on our Bitcoin Cash technical analysis, the current price of $541.70 presents a reasonable entry point for traders with appropriate risk management. The proximity to the $521.30 pivot support provides a logical stop-loss level, limiting downside risk to approximately 4%.

Entry Strategy:
- Primary entry: $540-$545 range (current levels)
- Aggressive entry: $520-$525 on any dip to pivot support
- Stop-loss: $475 (below key support confluence)
- First target: $615 (immediate resistance)
- Extended target: $650 (if momentum continues)

Position sizing should remain conservative given the mixed technical signals. A 2-3% portfolio allocation allows for meaningful upside participation while limiting downside exposure during this uncertain technical environment.

BCH Price Prediction Conclusion
Our comprehensive BCH price prediction anticipates a 13-15% rally toward $615 resistance over the next 1-2 weeks, with medium confidence based on current technical conditions. The combination of oversold Bollinger Band positioning and neutral RSI provides the foundation for this bullish Bitcoin Cash forecast.

However, the negative MACD histogram demands caution, suggesting traders should remain prepared for potential volatility. The key validation signal will be BCH's ability to reclaim the $564.64 middle Bollinger Band on sustained volume.

Critical indicators to monitor include MACD histogram improvement, RSI movement above 50, and most importantly, price action around the $615.30 resistance level. Failure to break this level within the next 7-10 days would necessitate a reassessment of our buy or sell BCH recommendation toward a more neutral stance.

The timeline for this prediction spans 2-3 weeks, with initial confirmation expected within 5-7 trading days as BCH approaches the first resistance cluster.

Image source: Shutterstock

bch price forcast
bch price prediction

Peter Zhang
Oct 12, 2025 20:11

ATOM price prediction shows mixed signals with immediate resistance at $4.35 but potential for $15+ medium-term as Cosmos tests critical support levels around $3.29.

The latest ATOM price prediction presents a complex technical picture as Cosmos (ATOM) trades at $3.52, showing signs of both immediate bearish pressure and medium-term bullish potential. With recent analyst forecasts ranging from conservative $4.08 targets to ambitious $15.10 projections, determining the most probable Cosmos forecast requires careful analysis of current market dynamics.

ATOM Price Prediction Summary
• ATOM short-term target (1 week): $4.08 (-16% downside risk to current levels)
• Cosmos medium-term forecast (1 month): $4.35-$4.72 range (+24-34% upside potential)
• Key level to break for bullish continuation: $4.35 (immediate resistance)
• Critical support if bearish: $3.29 (Bollinger Band lower boundary)

Recent Cosmos Price Predictions from Analysts
Current analyst sentiment reveals a notable divergence in ATOM price prediction methodologies. Changelly's consecutive bearish forecasts from October 8-12 show a systematic downward revision, with their ATOM price target declining from $4.19 to $4.08 over five trading sessions. This represents a consistent bearish bias focused on short-term momentum indicators.

Contrasting sharply with these conservative projections, PricePredictions.com maintains an optimistic medium-term outlook with a $15.10 target, suggesting potential 329% appreciation from current levels. CoinCodex offers a middle-ground perspective with their $4.35 Cosmos forecast, representing a 24% upside that aligns more closely with technical resistance levels.

The consensus appears divided between immediate bearish pressure and medium-term recovery potential, creating an environment where precise entry timing becomes crucial for maximizing returns.

ATOM Technical Analysis: Setting Up for Consolidation Before Breakout
The current Cosmos technical analysis reveals ATOM trading significantly below all major moving averages, with the price at $3.52 sitting 34% below the 52-week high of $5.38. However, several indicators suggest the selling pressure may be nearing exhaustion.

The RSI reading of 39.18 indicates ATOM remains in neutral territory, avoiding oversold conditions that typically accompany major capitulation events. More importantly, the Bollinger Band position of 0.16 places ATOM very close to the lower band at $3.29, historically a level where bounce attempts often originate.

The MACD histogram reading of -0.0865 confirms bearish momentum remains intact, but the magnitude suggests momentum is weakening rather than accelerating. The 24-hour trading range of $3.04-$3.54 demonstrates significant volatility with a 12.19% daily gain, indicating active buyer interest at lower levels.

Volume analysis from Binance shows $13.4 million in 24-hour turnover, providing adequate liquidity for institutional accumulation without significant price impact. This volume profile supports the thesis that current price action represents consolidation rather than distribution.

Cosmos Price Targets: Bull and Bear Scenarios
Bullish Case for ATOM
The primary bullish ATOM price target centers on the $4.35 level, representing the convergence of multiple technical factors. This level coincides with the previous month's rejection point mentioned in CoinCodex analysis and sits just below the immediate resistance zone.

A successful break above $4.35 would target the Bollinger Band middle line at $4.00, followed by the upper band at $4.72. The ambitious $15.10 medium-term projection from PricePredictions.com requires ATOM to reclaim the $4.97 strong resistance level and establish a new uptrend structure.

Key bullish catalysts include RSI momentum divergence above 45, MACD histogram turning positive, and daily closes above the 20-day SMA at $4.00. The 24-hour high at $3.54 serves as the immediate breakout confirmation level.

Bearish Risk for Cosmos
The primary bearish scenario involves a breakdown below the critical $3.29 support level, which represents the Bollinger Band lower boundary. Such a move would target the 52-week low at $2.95, representing additional 16% downside from current levels.

The most concerning technical development would be RSI falling below 35, indicating oversold momentum that could trigger additional selling pressure. MACD histogram expanding beyond -0.10 would confirm accelerating bearish momentum.

Risk factors include broader cryptocurrency market weakness, regulatory concerns affecting interoperability protocols, and failure to hold the psychological $3.00 support level.

Should You Buy ATOM Now? Entry Strategy
Based on current Cosmos technical analysis, the optimal buy or sell ATOM decision depends on risk tolerance and investment timeframe. Conservative investors should wait for confirmation above $3.54 (24-hour high) before establishing positions, with stops placed below $3.29.

Aggressive traders might consider accumulating in the $3.29-$3.52 range, anticipating a bounce from Bollinger Band support. This strategy requires tight risk management with stops below $3.00 and position sizing limited to 2-3% of portfolio allocation.

The most prudent approach involves scaling into positions between $3.30-$3.50, targeting the $4.35 resistance for initial profit-taking. This provides a favorable 2:1 risk-reward ratio while respecting the current technical setup.

For medium-term investors, dollar-cost averaging into ATOM below $4.00 appears justified given the significant discount to historical averages and analyst price targets ranging up to $15.10.

ATOM Price Prediction Conclusion
The comprehensive ATOM price prediction analysis suggests a medium confidence forecast targeting $4.35 within 30 days, representing 24% upside potential from current levels. This Cosmos forecast balances the immediate bearish sentiment from recent analyst revisions with the compelling technical setup near Bollinger Band support.

Key indicators to monitor include RSI breaking above 45 for bullish confirmation or falling below 35 for bearish invalidation. The $3.29 support level serves as the critical decision point, with breaks below targeting $2.95 and holds above enabling the move toward $4.35.

The prediction timeline spans 2-4 weeks for initial targets, with the ambitious $15.10 medium-term projection requiring 3-6 months and broader market cooperation. Current technical conditions favor patient accumulation over aggressive speculation, making ATOM an intriguing medium-term opportunity for risk-tolerant investors.

Image source: Shutterstock

atom price forcast
atom price prediction

XRP is showing signs of renewed weakness as the price struggles to hold above $2.85, signaling a potential continuation of the short-term downtrend. Analysts note that XRP's price action mirrors broader market weakness seen in Bitcoin and Ethereum, suggesting that the current decline could extend further if key support levels fail.

XRP tumbled more than 50% during a sharp crypto market downturn, triggering $700 million in liquidations. Although the asset swiftly rebounded, analysts and social media users continue to speculate that the flash crash may have been the result of coordinated market activity.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

The Ethereum price has had one of the most interesting price actions so far in 2025, dropping to as low as $1,500 early on in the year. The “king of altcoins” has since gone on to forge a new all-time high at $4,946, while outperforming most large-cap crypto assets along the way.

As a result of the market-wide downturn, the Ethereum price has caused pain among investors, falling by double digits to around $3,750 on Friday, October 10. However, this latest spike in volatility has led to the question — does ETH still have some fuel left in the tank, or is the altcoin done in this cycle?

ETH Exchange Withdrawal Count In Downtrend: Alphractal
In a recent post on X, market analytics firm Alphractal shared an interesting on-chain insight into the current outlook for the Ethereum price. According to the blockchain platform, the price of ETH doesn’t appear to have reached its peak in the current cycle.

This price evaluation is based on the Exchange Withdrawal Count metric, which measures the number of crypto withdrawals made from an exchange over a certain period. This indicator offers insight into the volume of a cryptocurrency (Ethereum, in this case) leaving a centralized exchange.

Alphractal revealed that the spikes in the Exchange Withdrawal Count have often coincided with Ethereum price tops. This means that investors tend to withdraw their assets from exchanges as the price of ETH surges to new highs in the previous bull runs. 

Source: @Alphractal on X
However, Alphractal highlighted a deviation from this historical pattern following Ethereum’s latest run to a new all-time high. According to the on-chain firm, the Exchange Withdrawal Count has been on a steady decline—rather than a rise—as the Ethereum price moves towards a fresh high.

Ultimately, Alphractal suggested that this deviation from the usual trend could be a signal that the Ethereum price has not yet hit its peak in this cycle. Nevertheless, the on-chain firm noted that the second-largest cryptocurrency could also be about to witness a historical exception, especially when you consider the recent price downturn.

Ethereum Price At A Glance
As of this writing, the price of ETH sits just above $3,700, reflecting a 3% decline in the past 24 hours. According to data from CoinGecko, the altcoin’s value is down by more than 16% in the last seven days.

The price of ETH on the daily timeframe | Source: ETHUSDT chart on TradingView
Featured image from iStock, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Opeyemi Sule is a passionate crypto enthusiast, a proficient content writer, and a journalist at Bitcoinist. Opeyemi creates unique pieces unraveling the complexities of blockchain technology and sharing insights on the latest trends in the world of cryptocurrencies. Opeyemi enjoys reading poetry, chatting about politics, and listening to music, in addition to his strong interest in cryptocurrency.

Log In

Help

Join The Motley Fool

By Jonathan Ponciano
–
Oct 12, 2025 at 12:19PM

Key Points

Benson Investment Management bought 31,240 shares of Keysight Technologies worth an estimated $5.5 million in the third quarter.

The investment marks a new position for Benson, which did not report owning Keysight Technologies shares in the second quarter.

The position is not ranked among the fund’s top five holdings.

On Friday, Benson Investment Management Company, Inc. disclosed a new position in Keysight Technologies (KEYS -7.00%), acquiring 31,240 shares for approximately $5.5 million as of September 30, according to its latest SEC filing.

What HappenedBenson Investment Management Company disclosed a new stake in Keysight Technologies, acquiring 31,240 shares valued at about $5.5 million as of September 30. The acquisition was reported in the firm’s latest Form 13-F, filed with the U.S. Securities and Exchange Commission on Friday. This is the first reported holding in Keysight Technologies for the fund during the third quarter.

What Else to KnowThis new position represents about 2% of Benson Investment Management’s 13F reportable AUM as of September 30.

Top holdings after the filing:

GLD: $14.7 million (5.0% of AUM)GOOGL: $14.6 million (4.98% of AUM)MSFT: $12.8 million (4.38% of AUM)NVDA: $11.4 million (3.89% of AUM)AMZN: $9.39 million (3.2% of AUM)As of October 9, 2025, shares of Keysight Technologies were priced at $159.49, up about 0.3% over the year and underperforming the S&P 500 by about 12 percentage points during the same period.

Company OverviewMetricValueRevenue (TTM)$5.2 billionNet Income (TTM)$544 millionPrice (as of market close 2025-10-09)$159.49Company SnapshotKeysight Technologies offers electronic design and test solutions, including EDA software, RF and microwave test equipment, oscilloscopes, analyzers, and a wide range of hardware and software platforms for measurement and analysis.The company generates revenue through direct sales, distributors, resellers, and manufacturer's representatives, providing both products and recurring support, training, and consulting services.It serves commercial communications, networking, aerospace, defense, government, automotive, energy, semiconductor, electronics, and education sectors globally.Keysight Technologies is a global leader in electronic design and test solutions, with a diverse product portfolio supporting industries from communications to aerospace and semiconductors. The company leverages its deep engineering expertise and broad product suite to address complex measurement and analysis needs across multiple sectors.

Foolish TakeBenson Investment Management’s new $5.5 million stake in Keysight Technologies stands out as a calculated pivot toward high-quality industrial tech exposure within a portfolio otherwise dominated by mega-cap names like Alphabet, Microsoft, Nvidia, and Amazon.

That positioning comes as Keysight continues to defy the broader industrial slowdown. In its third fiscal quarter of 2025, the company reported revenue of $1.35 billion, up 11% year-over-year, and non-GAAP EPS of $1.72, beating guidance on both metrics. Management raised full-year guidance again after orders rose 7%, led by double-digit growth in commercial communications and steady defense demand. Aerospace, defense, and semiconductor testing also contributed to strong results, helping offset near-term wireless softness and tariff headwinds.

For Benson, the move complements a tech-heavy lineup anchored by software and AI winners—a potential hedge against overconcentration in the digital economy’s front end. By adding Keysight, the firm gains exposure to the hardware and R&D infrastructure enabling that same AI expansion. While Keysight shares have been mostly flat this year—up just 0.3%—prices are well below their 2021 highs, suggesting room for upside if the testing and measurement cycle strengthens into fiscal 2026.

Glossary13F reportable AUM: The total value of assets under management that an institutional investment manager must report quarterly to the SEC.
Form 13F: A quarterly SEC filing by institutional investment managers disclosing their equity holdings and certain other securities.
Position: The amount of a particular security or asset held by an investor or fund.
Top holdings: The largest investments in a fund's portfolio, typically ranked by market value.
Stake: The ownership interest or investment a person or entity holds in a company.
Direct sales: Products or services sold directly from the company to the customer, without intermediaries.
Distributors: Third-party companies that buy products from manufacturers to resell to retailers or end customers.
Resellers: Businesses that purchase products to sell them to end users, often adding value or support.
Manufacturer's representatives: Independent agents who sell a manufacturer's products to customers, usually within a specific territory.
EDA software: Electronic Design Automation software, used by engineers to design and test electronic systems and circuits.
Oscilloscopes: Electronic instruments that display and analyze the waveform of electronic signals.
TTM: The 12-month period ending with the most recent quarterly report.

About the Author

Jonathan Ponciano is a contributing stock market analyst at The Motley Fool. He has nearly a decade of experience as a financial journalist, most recently as an editor and senior reporter at Forbes focused on markets, technology, and entrepreneurship. Jonathan has also written for Investopedia and the Los Angeles Business Journal. He holds a dual B.A. in Business Journalism and Economics from the University of North Carolina at Chapel Hill and an M.B.A. from Columbia Business School. A North Carolina native now based in New York City, Jonathan has also lived in Mexico City and Los Angeles.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.